Mainstream

Abeona targets treating 10–14 zevaskyn patients in 2025 while securing $155m prv sale to extend runway

Abeona targets treating 10–14 ZEVASKYN patients in 2025 while securing $155M PRV sale to extend runway

Abeona targets treating 10–14 ZEVASKYN patients in 2025 while securing $155M PRV sale to extend runway

Post ContentabeoRead More

You might also be interested in reading Stellar Lumens bears press advantage as XLM slides toward April support.

May 16, 2025
In Mainstream